BEUDAMED
    FDA Adverse Event Injury Summary report: N

    MEDTRONIC LEAD

    MDR report key: 25283128 · Received May 26, 2026

    Report

    Report Number
    2182208-2026-30464
    Event Type
    Injury
    Date Received
    May 26, 2026
    Date of Event
    January 1, 2026
    Report Date
    May 26, 2026
    Manufacturer
    MEDTRONIC, INC.
    Product Code
    DXY
    Adverse Event
    Yes
    Report Source
    Manufacturer report
    Reporter Location
    SP
    Reporter Occupation
    OTHER HEALTH CARE PROFESSIONAL
    Health Professional
    Yes

    Narratives

    Additional Manufacturer Narrative · 0

    THIS INFORMATION IS BASED ENTIRELY ON JOURNAL LITERATURE. MEDTRONIC WAS MADE AWARE OF THIS EVENT THROUGH A SEARCH OF LITERATURE PUBLICATIONS. THIS EVENT OCCURRED OUTSIDE THE US. PATIENT INFORMATION IS LIMITED DUE TO CONFIDENTIALITY CONCERNS. OF NOTE, MULTIPLE PATIENTS AND MULTIPLE MANUFACTURERS WERE NOTED IN THE ARTICLE; HOWEVER, A ONE-TO-ONE CORRELATION COULD NOT BE MADE WITH UNIQUE PRODUCT SERIAL NUMBERS. THE BASELINE GENDER/AGE CHARACTERISTICS IS MALE/67 YEARS OLD. THE MODEL LISTED IN THE REPORT IS A REPRESENTATIVE OF THE MODEL FAMILY, AS THERE IS NO SPECIFIC MODEL LISTED. WITHOUT A DEVICE SERIAL NUMBER, THE MANUFACTURING DATE CANNOT BE DETERMINED. SINCE NO DEVICE ID WAS PROVIDED, IT IS UNKNOWN IF THIS EVENT HAS BEEN PREVIOUSLY REPORTED. A REQUEST FOR ADDITIONAL INFORMATION WAS MADE. IF ADDITIONAL INFORMATION IS OBTAINED REGARDING THIS EVENT, IT WILL BE ADDED, AND A SUPPLEMENTAL REPORT WILL BE SUBMITTED ACCORDINGLY. REFERENCED ARTICLE: COST-UTILITY ANALYSIS OF LEFT BUNDLE BRANCH AREA VERSUS BIVENTRICULAR PACING FOR CARDIAC RESYNCHRONIZATION THERAPY: A MULTICENTER, PROSPECTIVE, QUASI-EXPERIMENTAL STUDY. JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY. 2026. 37:257¿267. DOI: 10.1111/JCE.70202. MEDTRONIC SUBMITS THIS REPORT TO COMPLY WITH FDA REGULATIONS 21 CFR PARTS 4 AND 803. MEDTRONIC HAS MADE REASONABLE EFFORTS TO PROVIDE AS MUCH RELEVANT INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE OF THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEE CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. ANY REQUIRED FIELDS THAT ARE UNPOPULATED ARE BLANK BECAUSE THE INFORMATION IS CURRENTLY UNKNOWN OR UNAVAILABLE. MEDTRONIC WILL SUBMIT A SUPPLEMENTAL REPORT IF ADDITIONAL RELEVANT INFORMATION BECOMES KNOWN.

    Description of Event or Problem · 0

    LITERATURE WAS REVIEWED REGARDING A COMPARISON OF THE COST UTILITY OF LEFT BUNDLE BRANCH AREA PACING (LBBAP) CARDIAC RESYNCHRONIZATION THERAPY (CRT) WITH BIVENTRICULAR PACING (BVP) CRT IN PATIENTS WITH HEART FAILURE AND AN INDICATION FOR CRT. THE AUTHORS DESCRIBED ONE PATIENT DEATH IN THE LBBAP GROUP; HOWEVER, THE CAUSE OF DEATH WAS UNKNOWN AND DESCRIBED AS CARDIOVASCULAR. THERE WERE PATIENTS IN EACH GROUP WHO WERE HOSPITALIZED DUE TO DEVICE/POCKET INFECTIONS. ONE PATIENT IN THE BVP GROUP EXPERIENCED A CORONARY SINUS PERFORATION DURING THE IMPLANT PROCEDURE WHICH DID NOT CAUSE SIGNIFICANT BLEEDING OR HEMODYNAMIC COMPROMISE. THE STATUS OF THE DEVICES AND LEADS IS UNKNOWN. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.

    Devices

    Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
    425976 MEDTRONIC LEAD IMPLANTABLE PACEMAKER PULSE-GENERATOR DXY MEDTRONIC, INC. MDT-LEAD

    Patients

    Seq Age Sex Outcome Treatment
    1